BICLUSTER_ID : UPREG-22
PATHOGENS /2/ : yersinia enterocolitica,ehrlichia chaffeensis
TARGETS /82/ : LTF, ACE, LCN2, NDUFA3, CD44, NDUFV1, NDUFA1, NDUFS8, CYSLTR2, IFNG, CD86, SDHC, NDUFA8, NDUFB7, NDUFS6, IL2RB, XDH, JAK2, PPARG, MCM6, TNFRSF1A, SERPINE1, NDUFA12, IL1R1, NDUFC1, NDUFB10, NDUFV2, NDUFS5, NDUFA13, CCL20, NDUFS7, BCL2, CCL2, SERPINB2, PROCR, GLA, VCAM1, SLC1A5, AMPD3, NDUFA10, NDUFB4, CCL5, CD55, NDUFA9, ANXA1, HMOX1, NDUFB6, NDUFA4, IL6, SDHD, ABP1, TNF, LCK, NDUFA5, NDUFB8, SDHA, CYP1B1, NDUFB5, NDUFS1, SAT1, UQCRC1, NDUFA6, NFKB1, ITGB3, NDUFAB1, NDUFB2, SELE, NDUFS3, PLA2G4A, SDHB, JUN, ATP5D, TNFRSF1B, IL3RA, NDUFB9, PIM1, NDUFB3, PPBP, IL12B, TAP1, MAPKAPK2, PLAUR
Gene SetLeading Edge Genes
CORUM RESPIRATORY CHAIN COMPLEX I HOLOENZYME MITOCHONDRIALNDUFV2, NDUFS5, NDUFA13, NDUFS7, NDUFA3, NDUFA5, NDUFB8, NDUFV1, NDUFA1, NDUFB9, NDUFA10, NDUFB5, NDUFB4, NDUFS8, NDUFS1, NDUFA8, NDUFB3, NDUFB7, NDUFA6, NDUFA9, NDUFS6, NDUFB6, NDUFA4, NDUFAB1, NDUFB2, NDUFS3, NDUFB11, NDUFA12, NDUFB10, NDUFC1
MOOTHA VOXPHOSATP5I, NDUFA3, UQCR, NDUFA5, NDUFB8, SDHA, ATP5H, NDUFB5, CYC1, NDUFS1, NDUFS8, SDHC, NDUFA8, ATP5O, UQCRC1, NDUFB7, NDUFA6, NDUFS6, ATP5G1, MBD3, ATP5J2, ATP5J, ATP5E, NDUFAB1, COX6C, NDUFB2, UQCRC2, ATP5F1, NDUFS3, SURF1, NDUFC1, NDUFS5, ATP5C1, NDUFS7, SDHB, ATP5D, NDUFA10, COX5B, NDUFB4, NDUFB3, NDUFA9, COX4I1, NDUFA4, NDUFB6, COX7C, SDHD
NETPATH IL 4 PATHWAY UPCH25H, CYP1B1, RASA2, RIPK2, AIM1, TFEC, IFNG, CD86, EGR2, TNC, NFKB1, IL2RB, IBRDC3, RBMS1, IL10, MCM6, TIMP3, SELE, CSPG2, UPP1, FGL2, SLC38A1, MAD2L1, JUN, PCDH7, BCL2, ETV3, CCL2, MCM2, CDC45L, SOCS3, VCAM1, IL1RN, SOCS1, S100A9, PTX3, MCM4, ANXA1, REL, MXD1, SCGB3A1, KLF4, TOX, IL6, RSAD2
GERY CEBP TARGETSGADD45B, LCN2, SLFN2, HBEGF, SLFN4, GLA, PROCR, SERPINB2, IFI203 /// IFI204 //, PIM1, SAT1, MAFK, PTX3, HMOX1, XDH, CXCL1, JUNB, KLF4, S100A8, PPARG, IFI204 /// LOC672547, GADD45G, CXCL5, ATF3, IFRD1, TGTP, CSPG2, PLAUR
NETPATH IL 1 PATHWAY UPRHOB, CCL20, LCN2, MMP14, JUN, CCL2, HBEGF, SERPINB2, PRG1, CCL7, SOD3, AMPD3, MT2A, CXCL2, CCL4, PTX3, RGS4, NFKB1, CXCL1, CDC6, IL1A, CXCL5, CHI3L1, IL6, SERPINE1, PBEF1
NETPATH IL 2 PATHWAY UPPCNA, LCK, PTPN22, PMAIP1, CCND2, NFKB1, IFIT1, FUBP1, CSF1, GADD45G, IL10, LCP2, RGS1, CCL3, SERPINE1, IRF1, BLM, UPP1, IL1R1, JUN, TRAFD1, SOCS3, SLC1A5, SOCS1, IER3, CCL4, KLF6, PTPRC, CCR1, TRIM21, ETS2, PRKX, IL6, DAXX, PBEF1, PLAUR, TNF, MX1
NETPATH TGFBETA RECEPTOR PATHWAY DOWNLTF, LCN2, MAP3K8, SLPI, SOD3, CCND2, EGR2, CASP4, NFKBIZ, IFIT1, FMO2, FUBP1, CXCL1, CSF1, EDN1, CDC6, PPARG, GBP2, LCP2, SERPINB9, TNFAIP3, IFRD1, AKAP2, IL1R1, JUN, PCDH7, EVI2A, CCL2, VCAM1, CCL7, IL1RN, IFIT3, ANGPT2, SOCS1, PLEKHQ1, CD36, IFIT2, TAP1, ATF3, MAPKAPK2, DAXX
NETPATH IL 5 PATHWAY UPPLSCR1, CCL2, CD44, HBEGF, IL3RA, SLC1A5, PIM1, CD55, CD24, EGR2, CASP4, IER3, NFKB1, REL, IL1A, LCP2, CCL3, ZYX, ABP1, UPP1
NETPATH KIT RECEPTOR PATHWAY UPPLA2G4A, GDF15, FUBP1, HMOX1, JUNB, CCL2, TAP1, IL6, SOCS1, CCL5, PIM1, TNF, KITLG, IER3
NCI ATF2 PATHWAYBCL2, DUSP10, JUN, BRCA1, TGFB2, SOCS3, IL6, ATF3, SELE, IFNG
NETPATH IL 6 PATHWAY UPGADD45B, CXCL1, JUN, JUNB, CD44, HBEGF, MAP3K8, PPARG, SOCS3, MAFF, SOCS1, IRF1, PIM1, MX1, TNF
NCI IL23PATHWAYSOCS3, NFKB1, IL6, CXCL1, JAK2, CCL2, CXCL9, TNF
SA MMP CYTOKINE CONNECTIONACE, CSF1, CD44, SELL, TNFRSF1B, TGFB2, TNFRSF1A, TNF
NETPATH IL 4 PATHWAY DOWNCCL20, GADD45B, CCL2, GBP2, CHI3L1, IL6, GEM, CYSLTR2, IRF1, CXCL2, MX1, TNF
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CD44, CXCL5, CCL3, CCL5, CXCL2, CD86, CCL4
NETPATH IL 3 PATHWAY UPCSF1, CCL2, SOCS3, IL3RA, CCL7, CCL3, SOCS1, CD86, TNF, CCL4
NCI IL27PATHWAYIL12B, IL6, JAK2, STAT2, TNF
NCI IL12 2PATHWAYNFKB1, GADD45B, LCK, JAK2, GADD45G, CCL3, SOCS1, RIPK2, IL1R1, CCL4
NCI EXOCYTOSIS OF ALPHA GRANULE ITGB3, GP1BB, PPBP, SERPINE1, TIMP1, CD36
ST STAT3 PATHWAYIL6, JAK2
NCI IL4 2PATHWAYPARP14, JAK2, IL10, SOCS3, HMGA1, ITGB3, SOCS1, DOK2, EGR2
NETPATH IL 9 PATHWAY UPSOCS3, CCL7, LCN2, CCL3, CCL2, JUNB
BIOCARTA IL10 PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
HUANG FOXA2 TARGETS DN
RADAEVA RESPONSE TO IFNA1 UP
LUI THYROID CANCER CLUSTER 4
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
CORUM MCL1-NOXA COMPLEX
WANG SMARCE1 TARGETS UP
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
LIN SILENCED BY TUMOR MICROENVIRONMENT
BOYAULT LIVER CANCER SUBCLASS G56 DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR UP
KANG DOXORUBICIN RESISTANCE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
PAL PRMT5 TARGETS DN
MCBRYAN PUBERTAL BREAST 3 4WK UP
CERVERA SDHB TARGETS 1 UP
NCI REG GR PATHWAY
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
SENGUPTA NASOPHARYNGEAL CARCINOMA UP
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
AMIT EGF RESPONSE 120 HELA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
GAJATE RESPONSE TO TRABECTEDIN UP
BEGUM TARGETS OF PAX3 FOXO1 FUSION DN
HELLER SILENCED BY METHYLATION UP
KEGG CELL ADHESION MOLECULES CAMS
GOZGIT ESR1 TARGETS DN
SMID BREAST CANCER LUMINAL B DN
BIOCARTA MONOCYTE PATHWAY
LEE LIVER CANCER CIPROFIBRATE UP
BERENJENO TRANSFORMED BY RHOA UP
SASSON RESPONSE TO GONADOTROPHINS DN
DORN ADENOVIRUS INFECTION 24HR DN
MARSON FOXP3 TARGETS STIMULATED UP
BIOCARTA IL17 PATHWAY
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
REACTOME G ALPHA I SIGNALLING EVENTS
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN
SPIRA SMOKERS LUNG CANCER UP
CORUM IKBEPSILON-RELA-CREL COMPLEX
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
ABRAHAM ALPC VS MULTIPLE MYELOMA UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
KONDO PROSTATE CANCER WITH H3K27ME3
KEGG ASTHMA
NCI PLK PATHWAY
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
VERNELL RETINOBLASTOMA PATHWAY UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
SCHAVOLT TARGETS OF TP53 AND TP63
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
AMIT EGF RESPONSE 20 HELA
MARZEC IL2 SIGNALING UP
ENK UV RESPONSE EPIDERMIS DN
BOYLAN MULTIPLE MYELOMA C D DN
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
WU HBX TARGETS 2 DN
CORUM MCM COMPLEX
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
ST GAQ PATHWAY
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 8G
SANA RESPONSE TO IFNG UP
WU HBX TARGETS 1 UP
BOYLAN MULTIPLE MYELOMA PCA1 UP
LIANG SILENCED BY METHYLATION UP
NCI DNA REPLICATION
LU TUMOR ENDOTHELIAL MARKERS DN
MOSERLE IFNA RESPONSE
WANG METHYLATED IN BREAST CANCER
ONDER CDH1 TARGETS 1 DN
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP
BIOCARTA GRANULOCYTES PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
ELVIDGE HYPOXIA BY DMOG UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
KIM WT1 TARGETS 8HR UP
CHEOK RESPONSE TO HD MTX UP
CORUM ETS2-FOS-JUN COMPLEX
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
KUNINGER IGF1 VS PDGFB TARGETS DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
HAHTOLA SEZARY SYNDROM DN
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN
THUM MIR21 TARGETS HEART DISEASE UP
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
MCBRYAN PUBERTAL BREAST 4 5WK UP
NETPATH IL 1 PATHWAY
NETPATH TGFBETA RECEPTOR PATHWAY UP
NCI SYNDECAN 1 PATHWAY
BIOCARTA NKT PATHWAY
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
BROWNE INTERFERON RESPONSIVE GENES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BIOCARTA LAIR PATHWAY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 UP
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
BIOCARTA LYM PATHWAY
DUTTA APOPTOSIS VIA NFKB
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
BIOCARTA ERYTH PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
LEE LIVER CANCER MYC TGFA DN
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
NETPATH HEDGEHOG PATHWAY UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
SUNG METASTASIS STROMA DN
REACTOME PLATELET DEGRANULATION
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
NCI IL1PATHWAY
LEE LIVER CANCER MYC E2F1 UP
NCI IL2 1PATHWAY
BASSO HAIRY CELL LEUKEMIA DN
GEISS RESPONSE TO DSRNA UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
GENTILE UV HIGH DOSE DN
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME GPCR LIGAND BINDING
GRUETZMANN PANCREATIC CANCER UP
OKUMURA INFLAMMATORY RESPONSE LPS
ABE VEGFA TARGETS 2HR
VALK AML WITH CEBPA
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NAKAYAMA SOFT TISSUE TUMORS PCA2 UP
RODWELL AGING KIDNEY NO BLOOD UP
LEONARD HYPOXIA
GOZGIT ESR1 TARGETS UP
CHEN LVAD SUPPORT OF FAILING HEART DN
DORN ADENOVIRUS INFECTION 32HR DN
REACTOME DOWNSTREAM EVENTS IN GPCR SIGNALING
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
BIOCARTA CCR5 PATHWAY
BOYLAN MULTIPLE MYELOMA PCA1 DN
KEGG ECM RECEPTOR INTERACTION
SHIPP DLBCL VS FOLLICULAR LYMPHOMA DN
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
UROSEVIC RESPONSE TO IMIQUIMOD
BROWNE HCMV INFECTION 30MIN UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
SANA TNF SIGNALING DN
SWEET LUNG CANCER KRAS DN
BHATI G2M ARREST BY 2METHOXYESTRADIOL UP
BIOCARTA DC PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
REACTOME UNWINDING OF DNA
GOLDRATH ANTIGEN RESPONSE
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
RIGGI EWING SARCOMA PROGENITOR DN
DER IFN ALPHA RESPONSE UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
BERENJENO TRANSFORMED BY RHOA FOREVER DN
MARKS HDAC TARGETS DN
DAZARD UV RESPONSE CLUSTER G2
AMUNDSON DNA DAMAGE RESPONSE TP53
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
NAKAJIMA EOSINOPHIL
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D DN
NAKAJIMA MAST CELL
CASTELLANO NRAS TARGETS UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
LEE TARGETS OF PTCH1 AND SUFU DN
KEGG HEMATOPOIETIC CELL LINEAGE
STREICHER LSM1 TARGETS DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
NCI NFKAPPABCANONICALPATHWAY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS UP
NETPATH T CELL RECEPTOR PATHWAY UP
HELLER HDAC TARGETS DN
CROONQUIST NRAS VS STROMAL STIMULATION DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
NCI GLUCOSE ATP GLUCOSE 6 PHOSPHATE ADP
LU IL4 SIGNALING
WATTEL AUTONOMOUS THYROID ADENOMA DN
YAMASHITA METHYLATED IN PROSTATE CANCER
NCI VWF INTERACTION WITH COLLAGEN
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA NFKB PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2B
CHUANG OXIDATIVE STRESS RESPONSE UP
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
BRUECKNER TARGETS OF MIRLET7A3 DN
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
LINDSTEDT DENDRITIC CELL MATURATION D
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ZHU CMV 24 HR DN
CONRAD GERMLINE STEM CELL
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
GENTILE UV HIGH DOSE UP
MARKEY RB1 ACUTE LOF UP
NCI UNWINDING OF DNA
SARRIO EPITHELIAL MESENCHYMAL TRANSITION UP
XU AKT1 TARGETS 6HR
CORUM BRCA1-BARD1-BRCA2-DNA DAMAGE COMPLEX III
KEGG TYPE II DIABETES MELLITUS
YANG BREAST CANCER ESR1 BULK DN
POOLA INVASIVE BREAST CANCER UP
SABATES COLORECTAL ADENOMA UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
WOTTON RUNX TARGETS UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
KORKOLA TERATOMA
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
REACTOME ELECTRON TRANSPORT CHAIN
CHEBOTAEV GR TARGETS DN
PODAR RESPONSE TO ADAPHOSTIN UP
JAATINEN HEMATOPOIETIC STEM CELL DN
LEE LIVER CANCER E2F1 UP
KERLEY RESPONSE TO CISPLATIN UP
CHANDRAN METASTASIS UP
BOWIE RESPONSE TO TAMOXIFEN
HADDAD T LYMPHOCYTE AND NK PROGENITOR DN
ZHOU INFLAMMATORY RESPONSE LPS UP
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
WONG ENDMETRIUM CANCER UP
FURUKAWA DUSP6 TARGETS PCI35 UP
NETPATH IL 3 PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
STEARMAN LUNG CANCER EARLY VS LATE DN
BROCKE APOPTOSIS REVERSED BY IL6
NCI P53DOWNSTREAMPATHWAY
BIOCARTA ATM PATHWAY
ZHANG PROLIFERATING VS QUIESCENT
GAL LEUKEMIC STEM CELL DN
GENTILE UV LOW DOSE UP
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
WONG ENDMETRIUM CANCER DN
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
MOHANKUMAR TLX1 TARGETS DN
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
VANTVEER BREAST CANCER POOR PROGNOSIS
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
KANG GIST WITH PDGFRA UP
CORUM BRCA1 B COMPLEX
KANG IMMORTALIZED BY TERT UP
KHETCHOUMIAN TRIM24 TARGETS UP
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
NCI PLK2 4PATHWAY
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
HENDRICKS SMARCA4 TARGETS UP
MCCABE HOXC6 TARGETS DN
RIGGI EWING SARCOMA PROGENITOR UP
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
BUDHU LIVER CANCER METASTASIS DN
KEGG JAK STAT SIGNALING PATHWAY
DER IFN BETA RESPONSE UP
TSAI DNAJB4 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
CHANG POU5F1 TARGETS UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
NCI PTP1BPATHWAY
REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
SU THYMUS
SASSON RESPONSE TO FORSKOLIN DN
SMID BREAST CANCER NORMAL LIKE UP
BIOCARTA P53 PATHWAY
AMUNDSON GAMMA RADIATION RESISTANCE
VERRECCHIA RESPONSE TO TGFB1 C1
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
ELVIDGE HIF1A AND HIF2A TARGETS DN
CHEN HOXA5 TARGETS 9HR UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ENGELMANN CANCER PROGENITORS UP
LEE RECENT THYMIC EMIGRANT
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
REACTOME P38MAPK EVENTS
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
INGA TP53 TARGETS
KIM WT1 TARGETS UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
HESS TARGETS OF HOXA9 AND MEIS1 DN
AMIT EGF RESPONSE 120 MCF10A
IIZUKA RECURRENT LIVER CANCER
NETPATH WNT PATHWAY UP
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
SMID BREAST CANCER RELAPSE IN BONE DN
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
MATSUDA NATURAL KILLER DIFFERENTIATION
RUTELLA RESPONSE TO HGF UP
PRAMOONJAGO SOX4 TARGETS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
RUGO STRESS RESPONSE SUBSET G
VERHAAK AML WITH NPM1 MUTATED DN
REACTOME INORGANIC CATION ANION SLC TRANSPORTERS
BIOCARTA PML PATHWAY
TENEDINI MEGAKARYOCYTE MARKERS
CORUM ITGA2B-ITGB3-CD9-GP1B-CD47 COMPLEX
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
LINDSTEDT DENDRITIC CELL MATURATION A
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS
BASAKI YBX1 TARGETS DN
XU RESPONSE TO TRETINOIN UP
ELVIDGE HYPOXIA UP
KYNG DNA DAMAGE BY 4NQO OR UV
KOBAYASHI EGFR SIGNALING 24HR DN
NUYTTEN NIPP1 TARGETS UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU HGF TARGETS INDUCED BY AKT1 48HR UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
DELYS THYROID CANCER UP
NCI SYNTHESIS OF DNA
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
SEMENZA HIF1 TARGETS
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
BIOCARTA ETS PATHWAY
NCI NFAT TFPATHWAY
ONDER CDH1 TARGETS 3 DN
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
GU PDEF TARGETS UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
DAZARD RESPONSE TO UV NHEK UP
WINTER HYPOXIA METAGENE
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN
TAVOR CEBPA TARGETS UP
RAY ALZHEIMERS DISEASE
LU TUMOR VASCULATURE UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
NETPATH TNF ALPHA PATHWAY UP
NCI AMB2 NEUTROPHILS PATHWAY
NOJIMA SFRP2 TARGETS DN
CLASPER LYMPHATIC VESSELS DURING METASTASIS UP
BROWNE HCMV INFECTION 2HR UP
SESTO RESPONSE TO UV C3
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
CORUM MCM2-MCM4-MCM6-MCM7 COMPLEX
NETPATH IL 2 PATHWAY
SENESE HDAC2 TARGETS UP
ZHU CMV ALL UP
ROZANOV MMP14 TARGETS UP
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
SMID BREAST CANCER RELAPSE IN PLEURA DN
KEGG TYPE I DIABETES MELLITUS
AMIT DELAYED EARLY GENES
FOURNIER ACINAR DEVELOPMENT EARLY DN
NOJIMA SFRP2 TARGETS UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
KEGG P53 SIGNALING PATHWAY
AUJLA IL22 AND IL17A SIGNALING
LEE LIVER CANCER MYC TGFA UP
SCHUHMACHER MYC TARGETS DN
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SAGIV CD24 TARGETS DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS DN
COATES MACROPHAGE M1 VS M2 DN
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
ST INTERFERON GAMMA PATHWAY
MAHADEVAN RESPONSE TO MP470 DN
LEE INTRATHYMIC T PROGENITOR
TSAI RESPONSE TO RADIATION THERAPY
HARRIS HYPOXIA
KANG IMMORTALIZED BY TERT DN
KARAKAS TGFB1 SIGNALING
RUIZ TNC TARGETS DN
KAN RESPONSE TO ARSENIC TRIOXIDE
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
SOUCEK MYC TARGETS
BILBAN B CLL LPL DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
LEE NEURAL CREST STEM CELL DN
KEGG AUTOIMMUNE THYROID DISEASE
BERENJENO ROCK SIGNALING NOT VIA RHOA UP
CHIN BREAST CANCER COPY NUMBER UP
LEE LIVER CANCER ACOX1 UP
WANG ESOPHAGUS CANCER PROGRESSION UP
EINAV INTERFERON SIGNATURE IN CANCER
AMIT SERUM RESPONSE 40 MCF10A
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHU CMV 8 HR UP
BIOCARTA HSP27 PATHWAY
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
XU HGF TARGETS INDUCED BY AKT1 6HR
EBAUER TARGETS OF PAX3 FOXO1 FUSION UP
MATTIOLI MGUS VS PCL
ONDER CDH1 TARGETS 2 DN
GRADE COLON VS RECTAL CANCER UP
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
LIAN LIPA TARGETS 3M
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
FUJII YBX1 TARGETS UP
JISON SICKLE CELL DISEASE UP
CORUM 55S RIBOSOME MITOCHONDRIALMRPL9, MRPL2, MRPS18A, MRPS34, MRPL49, LACTB, MRPL12, MRPS30, MRPS5, MRPS22, MRPL44, MRPS18B, MRPL16, MRPL34, MRPL37, MRPL22, MRPS7, MRPL41, MRPS12, MRPS16, MRPL35, MRPS11, MRPL32, MRPS28, MRPL36, MRPS15, MRPL18, MRPL10, MRPS2, MRPS17, MRPL50, MRPL30, MRPS24, MRPL24, MRPS18C, MRPS21, MRPL43, MRPL53, MRPS31, MRPL39, MRPS35, MRPL48
TARTE PLASMA CELL VS PLASMABLAST UP
DASU IL6 SIGNALING UP
CORUM CDC2-PCNA-CCNB1-GADD45G COMPLEX
HUPER BREAST BASAL VS LUMINAL UP
FUNG IL2 TARGETS WITH STAT5 BINDING SITES T1
ZUCCHI METASTASIS DN
SMID BREAST CANCER BASAL UP
FERRANDO T ALL WITH MLL ENL FUSION UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bl6ehrlichia chaffeensis wakullaGeneSet Name
0.00000 0.00000CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL
0.00000 0.00000MOOTHA_VOXPHOS
0.00010 0.00000NETPATH_IL_4_PATHWAY_UP
0.00040 0.00116GERY_CEBP_TARGETS
0.00000 0.00022NETPATH_IL_1_PATHWAY_UP
0.00994 0.00006NETPATH_IL_2_PATHWAY_UP
0.06583 0.00363NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.00711 0.00000NETPATH_IL_5_PATHWAY_UP
0.00015 0.00015NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.05363 0.00196NCI_ATF2_PATHWAY
0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.00000 0.00020NCI_IL23PATHWAY
0.01474 0.00000SA_MMP_CYTOKINE_CONNECTION
0.00146 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00709 0.00004NETPATH_IL_7_PATHWAY_UP
0.00000 0.00000NETPATH_IL_3_PATHWAY_UP
0.02901 0.00004NCI_IL27PATHWAY
0.00272 0.00000NCI_IL12_2PATHWAY
0.00488 0.00047NCI_EXOCYTOSIS_OF_ALPHA_GRANULE_
0.03748 0.00083ST_STAT3_PATHWAY
0.01845 0.00320NCI_IL4_2PATHWAY
0.00016 0.00000NETPATH_IL_9_PATHWAY_UP
0.00108 0.00114BIOCARTA_IL10_PATHWAY
0.00010 0.00447MAHAJAN_RESPONSE_TO_IL1A_UP
0.00006 0.04046WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.04591 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00114 0.01394BIOCARTA_IL1R_PATHWAY
0.02841 0.00096HUANG_FOXA2_TARGETS_DN
0.00709 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.17950 0.00337LUI_THYROID_CANCER_CLUSTER_4
0.00618 0.00166BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.10787 0.00056MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.19600 0.12465CORUM_MCL1-NOXA_COMPLEX
0.00803 0.00533WANG_SMARCE1_TARGETS_UP
0.11861 0.00119AMIT_EGF_RESPONSE_480_HELA
0.01900 0.00032JEON_SMAD6_TARGETS_UP
0.05264 0.06953LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT
0.12093 0.00184BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.17439 0.11672KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.03296 0.00344TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.15328 0.00000KANG_DOXORUBICIN_RESISTANCE_UP
0.10560 0.04386GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.05253 0.05709HAN_SATB1_TARGETS_DN
0.05425 0.00109PAL_PRMT5_TARGETS_DN
0.02287 0.12943MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.15332 0.00183CERVERA_SDHB_TARGETS_1_UP
0.05415 0.14236NCI_REG_GR_PATHWAY
0.00012 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00069 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.02490 0.00000SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.17962 0.16910DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00029 0.00037AMIT_EGF_RESPONSE_120_HELA
0.07195 0.00161FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00050 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.02695 0.00261GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.09056 0.00717BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN
0.00251 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.05734 0.01808KEGG_CELL_ADHESION_MOLECULES_CAMS
0.00424 0.10943GOZGIT_ESR1_TARGETS_DN
0.00018 0.00000SMID_BREAST_CANCER_LUMINAL_B_DN
0.10000 0.00002BIOCARTA_MONOCYTE_PATHWAY
0.09770 0.00015LEE_LIVER_CANCER_CIPROFIBRATE_UP
0.06247 0.00506BERENJENO_TRANSFORMED_BY_RHOA_UP
0.06899 0.05689SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.00061 0.07444DORN_ADENOVIRUS_INFECTION_24HR_DN
0.04033 0.00435MARSON_FOXP3_TARGETS_STIMULATED_UP
0.05220 0.13139BIOCARTA_IL17_PATHWAY
0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.05158 0.01188AMIT_EGF_RESPONSE_40_MCF10A
0.01582 0.00052REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.17431 0.00000TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.04515 0.12283SPIRA_SMOKERS_LUNG_CANCER_UP
0.16341 0.13563CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.07095 0.04468CHASSOT_SKIN_WOUND
0.00016 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.14740 0.02131CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.01680 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00005 0.00050CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.01133 0.02695ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP
0.00176 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00038 0.00006MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.12852 0.02693KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.02752 0.00288KEGG_ASTHMA
0.10310 0.13384NCI_PLK_PATHWAY
0.03216 0.00017KIM_LRRC3B_TARGETS
0.06442 0.06560DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.13997 0.00003VERNELL_RETINOBLASTOMA_PATHWAY_UP
0.13271 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00504 0.00022CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.04121 0.14927SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.02538 0.00056DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00164 0.00539DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00934 0.00714SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00009 0.04300BIOCARTA_CYTOKINE_PATHWAY
0.18824 0.00184AMIT_EGF_RESPONSE_20_HELA
0.00021 0.00004MARZEC_IL2_SIGNALING_UP
0.10880 0.04439ENK_UV_RESPONSE_EPIDERMIS_DN
0.01871 0.00000BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.17993 0.00628FRIDMAN_SENESCENCE_UP
0.00030 0.08461CROMER_TUMORIGENESIS_UP
0.16824 0.00094WU_HBX_TARGETS_2_DN
0.05179 0.01856CORUM_MCM_COMPLEX
0.00018 0.00001MAHADEVAN_RESPONSE_TO_MP470_UP
0.01472 0.00156FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.18995 0.05938ST_GAQ_PATHWAY
0.16845 0.00035AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.01462 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00917 0.11208WU_HBX_TARGETS_1_UP
0.00219 0.00000BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.18005 0.03278LIANG_SILENCED_BY_METHYLATION_UP
0.03655 0.06080NCI_DNA_REPLICATION
0.17977 0.09565LU_TUMOR_ENDOTHELIAL_MARKERS_DN
0.00236 0.00000MOSERLE_IFNA_RESPONSE
0.00162 0.05272WANG_METHYLATED_IN_BREAST_CANCER
0.00405 0.13248ONDER_CDH1_TARGETS_1_DN
0.18236 0.00000CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
0.01449 0.00012BIOCARTA_GRANULOCYTES_PATHWAY
0.04457 0.11084LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.00028 0.00131ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00000 0.00265OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00000 0.00107PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.06776 0.07001KIM_WT1_TARGETS_8HR_UP
0.05339 0.00025CHEOK_RESPONSE_TO_HD_MTX_UP
0.09254 0.07788CORUM_ETS2-FOS-JUN_COMPLEX
0.10495 0.02625ELVIDGE_HIF1A_TARGETS_DN
0.01771 0.06248LI_CISPLATIN_RESISTANCE_DN
0.08927 0.00822KUNINGER_IGF1_VS_PDGFB_TARGETS_DN
0.00007 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.10113 0.00000HAHTOLA_SEZARY_SYNDROM_DN
0.00794 0.00004REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00011 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.13927 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.19272 0.01101THUM_MIR21_TARGETS_HEART_DISEASE_UP
0.00019 0.01382CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.06852 0.01520HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.06739 0.00085MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.02533 0.10950NETPATH_IL_1_PATHWAY
0.05939 0.01445NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.11366 0.07316NCI_SYNDECAN_1_PATHWAY
0.13260 0.00002BIOCARTA_NKT_PATHWAY
0.04032 0.01382MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.00006 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00735 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.09575 0.00022ROETH_TERT_TARGETS_UP
0.01867 0.08132TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00330 0.00063BIOCARTA_LAIR_PATHWAY
0.14573 0.00421CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.08169 0.00002OSADA_ASCL1_TARGETS_DN
0.00356 0.00144NUYTTEN_EZH2_TARGETS_UP
0.08081 0.00068BIOCARTA_LYM_PATHWAY
0.00201 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.14426 0.00650DER_IFN_GAMMA_RESPONSE_UP
0.00427 0.04480DAZARD_UV_RESPONSE_CLUSTER_G4
0.00872 0.00017MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.00000 0.00039ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.06839 0.00006RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00019 0.03887BIOCARTA_ERYTH_PATHWAY
0.10917 0.00276NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.18859 0.00000LEE_LIVER_CANCER_MYC_TGFA_DN
0.03258 0.00209NEWMAN_ERCC6_TARGETS_UP
0.07034 0.03294CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.07807 0.18274NETPATH_HEDGEHOG_PATHWAY_UP
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.00711 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00375 0.00070GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00980 0.04099SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00471 0.00000MARKEY_RB1_CHRONIC_LOF_DN
0.14961 0.07111SUNG_METASTASIS_STROMA_DN
0.02530 0.00006REACTOME_PLATELET_DEGRANULATION
0.00000 0.00032GESERICK_TERT_TARGETS_DN
0.00007 0.00009AMIT_SERUM_RESPONSE_120_MCF10A
0.04794 0.06247NCI_IL1PATHWAY
0.00848 0.00000LEE_LIVER_CANCER_MYC_E2F1_UP
0.11136 0.00191NCI_IL2_1PATHWAY
0.19035 0.04322BASSO_HAIRY_CELL_LEUKEMIA_DN
0.00109 0.00022GEISS_RESPONSE_TO_DSRNA_UP
0.00070 0.00050SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.09809 0.06742CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.08547 0.12305GENTILE_UV_HIGH_DOSE_DN
0.00240 0.04558BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.00000 0.02576ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.01873 0.01107REACTOME_GPCR_LIGAND_BINDING
0.11422 0.00009GRUETZMANN_PANCREATIC_CANCER_UP
0.00621 0.15053OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.13436 0.10928ABE_VEGFA_TARGETS_2HR
0.17974 0.05146VALK_AML_WITH_CEBPA
0.01090 0.04509KRIGE_AMINO_ACID_DEPRIVATION
0.00000 0.00070AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.01499 0.01388CHEN_HOXA5_TARGETS_6HR_UP
0.02220 0.00000SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.14410 0.01875NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
0.01452 0.00025RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.01346 0.00008LEONARD_HYPOXIA
0.06995 0.05224GOZGIT_ESR1_TARGETS_UP
0.16613 0.03472CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.00369 0.17242DORN_ADENOVIRUS_INFECTION_32HR_DN
0.15136 0.00095REACTOME_DOWNSTREAM_EVENTS_IN_GPCR_SIGNALING
0.00037 0.00166WU_CELL_MIGRATION
0.00029 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.10323 0.01308BIOCARTA_CCR5_PATHWAY
0.19056 0.13124BOYLAN_MULTIPLE_MYELOMA_PCA1_DN
0.00518 0.01805KEGG_ECM_RECEPTOR_INTERACTION
0.19676 0.04480SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN
0.03049 0.02499ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.03385 0.02715GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.07122 0.00376ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.00167 0.00001UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.10027 0.00435BROWNE_HCMV_INFECTION_30MIN_UP
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.02263 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.02559 0.00156CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.06271 0.14050SANA_TNF_SIGNALING_DN
0.06073 0.03050SWEET_LUNG_CANCER_KRAS_DN
0.08844 0.14048BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP
0.04231 0.01675BIOCARTA_DC_PATHWAY
0.00000 0.01086TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.06573 0.06615REACTOME_UNWINDING_OF_DNA
0.19042 0.00000GOLDRATH_ANTIGEN_RESPONSE
0.00000 0.00024BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.06189 0.00307DAUER_STAT3_TARGETS_UP
0.03905 0.18462RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.14030 0.00122DER_IFN_ALPHA_RESPONSE_UP
0.08832 0.03269ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00019 0.00102AMIT_EGF_RESPONSE_60_HELA
0.00332 0.00358BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.02398 0.00632MARKS_HDAC_TARGETS_DN
0.01250 0.00111DAZARD_UV_RESPONSE_CLUSTER_G2
0.13590 0.02275AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.00065 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00288 0.00014KEGG_ALLOGRAFT_REJECTION
0.11859 0.18484NAKAJIMA_EOSINOPHIL
0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00022 0.00000SANA_TNF_SIGNALING_UP
0.00000 0.00595BIOCARTA_INFLAM_PATHWAY
0.01129 0.01080SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.10800 0.00003TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
0.02843 0.01212NAKAJIMA_MAST_CELL
0.00019 0.00260CASTELLANO_NRAS_TARGETS_UP
0.00563 0.01027GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.00030 0.00004HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00019 0.00974SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.01450 0.01268LEE_TARGETS_OF_PTCH1_AND_SUFU_DN
0.00043 0.00000KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.13166 0.07041STREICHER_LSM1_TARGETS_DN
0.00000 0.00336UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.04764 0.02559NCI_NFKAPPABCANONICALPATHWAY
0.17334 0.00140CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.18828 0.01174NETPATH_T_CELL_RECEPTOR_PATHWAY_UP
0.04603 0.00974HELLER_HDAC_TARGETS_DN
0.04783 0.00000CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00037 0.00009GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08058 0.06016GOUYER_TATI_TARGETS_UP
0.15917 0.04858NCI_GLUCOSE___ATP____GLUCOSE_6_PHOSPHATE___ADP
0.00176 0.00009LU_IL4_SIGNALING
0.01530 0.01382WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.00195 0.02573YAMASHITA_METHYLATED_IN_PROSTATE_CANCER
0.16999 0.01285NCI_VWF_INTERACTION_WITH_COLLAGEN
0.00021 0.00547GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.05121 0.00699BIOCARTA_NFKB_PATHWAY
0.01562 0.00000LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.05687 0.12450CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.00069 0.00000KEGG_GRAFT_VERSUS_HOST_DISEASE
0.15490 0.00013VARELA_ZMPSTE24_TARGETS_UP
0.00054 0.00014REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00346 0.02134BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00309 0.00014KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00297 0.00001RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.05650 0.14476CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.00543 0.02903LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.03636 0.00089GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.17511 0.00007LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.00563 0.01247IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.08183 0.00250VALK_AML_CLUSTER_1
0.00021 0.00042AMIT_EGF_RESPONSE_40_HELA
0.00184 0.00174THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00708 0.00001TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.05165 0.08019ZHU_CMV_24_HR_DN
0.18156 0.02771CONRAD_GERMLINE_STEM_CELL
0.00000 0.00001HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.06848 0.04484RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.04436 0.19789GENTILE_UV_HIGH_DOSE_UP
0.01647 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.03748 0.02561NCI_UNWINDING_OF_DNA
0.18546 0.00120SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
0.00129 0.00053XU_AKT1_TARGETS_6HR
0.19263 0.13567CORUM_BRCA1-BARD1-BRCA2-DNA_DAMAGE_COMPLEX_III
0.01522 0.07767KEGG_TYPE_II_DIABETES_MELLITUS
0.17683 0.12165YANG_BREAST_CANCER_ESR1_BULK_DN
0.00857 0.00000POOLA_INVASIVE_BREAST_CANCER_UP
0.00162 0.03083SABATES_COLORECTAL_ADENOMA_UP
0.03654 0.00958TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.02147 0.00259RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.04686 0.18217WOTTON_RUNX_TARGETS_UP
0.12805 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.02158 0.15100KORKOLA_TERATOMA
0.14315 0.00031RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.07528 0.01515BIOCARTA_RANKL_PATHWAY
0.06859 0.00067DANG_REGULATED_BY_MYC_DN
0.01398 0.05726NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00000REACTOME_ELECTRON_TRANSPORT_CHAIN
0.00859 0.10081CHEBOTAEV_GR_TARGETS_DN
0.00000 0.00028PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00289 0.00000JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.00563 0.00000LEE_LIVER_CANCER_E2F1_UP
0.12090 0.00855KERLEY_RESPONSE_TO_CISPLATIN_UP
0.08488 0.13247CHANDRAN_METASTASIS_UP
0.00593 0.00001BOWIE_RESPONSE_TO_TAMOXIFEN
0.05879 0.00000HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.00000 0.00012ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00015 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.05178 0.03169WONG_ENDMETRIUM_CANCER_UP
0.16226 0.03289FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.19218 0.01643NETPATH_IL_3_PATHWAY_DOWN
0.14981 0.00000VANTVEER_BREAST_CANCER_ESR1_DN
0.01465 0.00064STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.04624 0.00000BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.11365 0.03452NCI_P53DOWNSTREAMPATHWAY
0.09780 0.02026BIOCARTA_ATM_PATHWAY
0.09313 0.13478ZHANG_PROLIFERATING_VS_QUIESCENT
0.06409 0.00000GAL_LEUKEMIC_STEM_CELL_DN
0.00394 0.07239GENTILE_UV_LOW_DOSE_UP
0.00029 0.00093HUANG_DASATINIB_RESISTANCE_UP
0.00034 0.00151HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.09943 0.13483WONG_ENDMETRIUM_CANCER_DN
0.00037 0.00000ZHANG_INTERFERON_RESPONSE
0.03094 0.00059CHANG_IMMORTALIZED_BY_HPV31_DN
0.05165 0.05650MOHANKUMAR_TLX1_TARGETS_DN
0.00954 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.00258 0.00483BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.10121 0.06524VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
0.01657 0.00163CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.12471 0.11433KANG_GIST_WITH_PDGFRA_UP
0.18362 0.16490CORUM_BRCA1_B_COMPLEX
0.10808 0.00075KANG_IMMORTALIZED_BY_TERT_UP
0.05355 0.00000KHETCHOUMIAN_TRIM24_TARGETS_UP
0.01137 0.00059HORIUCHI_WTAP_TARGETS_UP
0.00424 0.00000WOO_LIVER_CANCER_RECURRENCE_UP
0.16013 0.18729NCI_PLK2_4PATHWAY
0.12825 0.14182DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.00464 0.08227HENDRICKS_SMARCA4_TARGETS_UP
0.10115 0.19572MCCABE_HOXC6_TARGETS_DN
0.00782 0.01998RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.00924 0.15497CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.02833 0.01959BUDHU_LIVER_CANCER_METASTASIS_DN
0.00111 0.00097KEGG_JAK_STAT_SIGNALING_PATHWAY
0.04762 0.00214DER_IFN_BETA_RESPONSE_UP
0.06839 0.00356TSAI_DNAJB4_TARGETS_UP
0.00040 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00018 0.00000BASSO_CD40_SIGNALING_UP
0.08747 0.00332MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.13956 0.10270CHANG_POU5F1_TARGETS_UP
0.00683 0.00264TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.05840 0.11589ZERBINI_RESPONSE_TO_SULINDAC_UP
0.03028 0.00010WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.10130 0.03537NCI_PTP1BPATHWAY
0.05826 0.14751REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.01795 0.00028SU_THYMUS
0.15992 0.04793SASSON_RESPONSE_TO_FORSKOLIN_DN
0.01677 0.00000SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.09279 0.02366BIOCARTA_P53_PATHWAY
0.09360 0.01100AMUNDSON_GAMMA_RADIATION_RESISTANCE
0.13270 0.03557VERRECCHIA_RESPONSE_TO_TGFB1_C1
0.00000 0.00466ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.07814 0.00000KEGG_LEISHMANIA_INFECTION
0.04573 0.00619ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00807 0.00291CHEN_HOXA5_TARGETS_9HR_UP
0.05513 0.01783RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00038 0.03402NETPATH_EGFR1_PATHWAY_UP
0.00398 0.00003GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00489 0.01806CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.10778 0.01538ENGELMANN_CANCER_PROGENITORS_UP
0.03654 0.03366LEE_RECENT_THYMIC_EMIGRANT
0.02031 0.06472BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.15372 0.03582REACTOME_P38MAPK_EVENTS
0.00004 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.12689 0.00252BIOCARTA_ASBCELL_PATHWAY
0.01901 0.03717SENESE_HDAC1_TARGETS_UP
0.04786 0.00731LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.06039 0.00111INGA_TP53_TARGETS
0.00039 0.00017KIM_WT1_TARGETS_UP
0.00200 0.00252KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00006 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00086 0.03134AMIT_EGF_RESPONSE_120_MCF10A
0.09789 0.01342IIZUKA_RECURRENT_LIVER_CANCER
0.09285 0.17499NETPATH_WNT_PATHWAY_UP
0.18489 0.00001BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.07228 0.10522SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.01126 0.12832BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.11989 0.00288MATSUDA_NATURAL_KILLER_DIFFERENTIATION
0.04754 0.00473RUTELLA_RESPONSE_TO_HGF_UP
0.02844 0.00099PRAMOONJAGO_SOX4_TARGETS_UP
0.14239 0.04364YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.07743 0.02901LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.13681 0.01402RUGO_STRESS_RESPONSE_SUBSET_G
0.12021 0.00075VERHAAK_AML_WITH_NPM1_MUTATED_DN
0.10218 0.16223REACTOME_INORGANIC_CATION_ANION_SLC_TRANSPORTERS
0.19301 0.00285BIOCARTA_PML_PATHWAY
0.04211 0.00000TENEDINI_MEGAKARYOCYTE_MARKERS
0.19307 0.00526CORUM_ITGA2B-ITGB3-CD9-GP1B-CD47_COMPLEX
0.00042 0.13231SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00029 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.14876 0.09109REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.16659 0.18263BASAKI_YBX1_TARGETS_DN
0.14753 0.05395XU_RESPONSE_TO_TRETINOIN_UP
0.00031 0.00027ELVIDGE_HYPOXIA_UP
0.13756 0.01722KYNG_DNA_DAMAGE_BY_4NQO_OR_UV
0.17200 0.00013KOBAYASHI_EGFR_SIGNALING_24HR_DN
0.14988 0.16376NUYTTEN_NIPP1_TARGETS_UP
0.00058 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01826 0.05349XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.00294 0.01577VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.05105 0.00000DELYS_THYROID_CANCER_UP
0.03839 0.06248NCI_SYNTHESIS_OF_DNA
0.13887 0.00348KRISHNAN_FURIN_TARGETS_UP
0.00018 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.13918 0.00181KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00609 0.02278SEMENZA_HIF1_TARGETS
0.00079 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.01583 0.02668BIOCARTA_ETS_PATHWAY
0.15482 0.01648NCI_NFAT_TFPATHWAY
0.00026 0.00507ONDER_CDH1_TARGETS_3_DN
0.02280 0.06671HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.08481 0.10551GU_PDEF_TARGETS_UP
0.02528 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00177 0.00000LIAN_LIPA_TARGETS_6M
0.01128 0.05265DAZARD_RESPONSE_TO_UV_NHEK_UP
0.01519 0.01067WINTER_HYPOXIA_METAGENE
0.00056 0.13273GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.12908 0.00008REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN
0.06979 0.00085TAVOR_CEBPA_TARGETS_UP
0.03429 0.02902RAY_ALZHEIMERS_DISEASE
0.10590 0.13594LU_TUMOR_VASCULATURE_UP
0.03776 0.00161PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.17984 0.11655NETPATH_TNF_ALPHA_PATHWAY_UP
0.17478 0.00002NCI_AMB2_NEUTROPHILS_PATHWAY
0.01777 0.00758NOJIMA_SFRP2_TARGETS_DN
0.11573 0.00039CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP
0.00222 0.11885BROWNE_HCMV_INFECTION_2HR_UP
0.00078 0.01412SESTO_RESPONSE_TO_UV_C3
0.00272 0.00030GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.11086 0.03469CORUM_MCM2-MCM4-MCM6-MCM7_COMPLEX
0.10305 0.02892NETPATH_IL_2_PATHWAY
0.13212 0.14941SENESE_HDAC2_TARGETS_UP
0.03630 0.00083ZHU_CMV_ALL_UP
0.05243 0.00259ROZANOV_MMP14_TARGETS_UP
0.17945 0.06977KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00058 0.00011LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.01466 0.00056SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN
0.01506 0.00184KEGG_TYPE_I_DIABETES_MELLITUS
0.06744 0.00462AMIT_DELAYED_EARLY_GENES
0.15443 0.14329FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN
0.00037 0.00340NOJIMA_SFRP2_TARGETS_UP
0.19873 0.00170RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00000 0.00301OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.19355 0.07763KEGG_P53_SIGNALING_PATHWAY
0.00953 0.01045AUJLA_IL22_AND_IL17A_SIGNALING
0.02194 0.00000LEE_LIVER_CANCER_MYC_TGFA_UP
0.10584 0.09031SCHUHMACHER_MYC_TARGETS_DN
0.18788 0.00000LEE_LIVER_CANCER_DENA_UP
0.00022 0.00175HALMOS_CEBPA_TARGETS_UP
0.00069 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.18844 0.00451SAGIV_CD24_TARGETS_DN
0.00176 0.06523DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.00342 0.00022COATES_MACROPHAGE_M1_VS_M2_DN
0.12402 0.08442REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.17665 0.02959ST_INTERFERON_GAMMA_PATHWAY
0.00072 0.08720MAHADEVAN_RESPONSE_TO_MP470_DN
0.05333 0.12387LEE_INTRATHYMIC_T_PROGENITOR
0.01450 0.00053TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00029 0.00025HARRIS_HYPOXIA
0.15313 0.17901KANG_IMMORTALIZED_BY_TERT_DN
0.03294 0.00596KARAKAS_TGFB1_SIGNALING
0.01586 0.00009RUIZ_TNC_TARGETS_DN
0.00165 0.01034KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.19613 0.00000DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00018 0.00027SOUCEK_MYC_TARGETS
0.00270 0.00005BILBAN_B_CLL_LPL_DN
0.06984 0.00408IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00320 0.07482GENTILE_UV_LOW_DOSE_DN
0.02608 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.07443 0.17369LEE_NEURAL_CREST_STEM_CELL_DN
0.01127 0.00607KEGG_AUTOIMMUNE_THYROID_DISEASE
0.11133 0.08013BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP
0.10795 0.02449CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.02321 0.00000LEE_LIVER_CANCER_ACOX1_UP
0.02833 0.02738WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.06958 0.00004EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00000 0.00005AMIT_SERUM_RESPONSE_40_MCF10A
0.00993 0.06950HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00019 0.01785BROWNE_HCMV_INFECTION_4HR_UP
0.04574 0.03615WONG_ENDOMETRIAL_CANCER_LATE
0.00061 0.00000ZHU_CMV_8_HR_UP
0.01131 0.01244BIOCARTA_HSP27_PATHWAY
0.02310 0.06295HELLER_SILENCED_BY_METHYLATION_DN
0.05248 0.02732BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00043 0.00084TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00804 0.00000SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.02501 0.00223XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.02496 0.08885EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.12395 0.15152MATTIOLI_MGUS_VS_PCL
0.00022 0.00036ONDER_CDH1_TARGETS_2_DN
0.18524 0.14166GRADE_COLON_VS_RECTAL_CANCER_UP
0.06418 0.13254UDAYAKUMAR_MED1_TARGETS_DN
0.00979 0.02396SENESE_HDAC3_TARGETS_UP
0.06209 0.00000KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00252 0.00000LIAN_LIPA_TARGETS_3M
0.00423 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.04553 0.03830FUJII_YBX1_TARGETS_UP
0.06359 0.00000JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.00000CORUM_55S_RIBOSOME_MITOCHONDRIAL
0.12694 0.00567TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.00177 0.03956DASU_IL6_SIGNALING_UP
0.06582 0.13795CORUM_CDC2-PCNA-CCNB1-GADD45G_COMPLEX
0.00812 0.11431HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.14788 0.15804FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.04370 0.00899ZUCCHI_METASTASIS_DN
0.00022 0.00078SMID_BREAST_CANCER_BASAL_UP
0.18420 0.06622FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP